Instrument Inactif

Autres langues CytRx Corporation Nasdaq

Actions

US2328283013

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

27/03	LadRx Corporation publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
2023	LadRx Corporation annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

LadRx: Q1 Earnings Snapshot	15/05
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C Results in XOMA Making a $1 Million Milestone Payment to LadRx	12/01
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	11/01
LadRx Issues 2024 Update to Shareholders	09/01
LadRx: Q3 Earnings Snapshot	14/11
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
LadRx : Modification to Rights of Security Holders - Form 8-K	11/09/23
LadRx: Q2 Earnings Snapshot	14/08/23
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Investor Presentation: July 2023	15/07/23
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation	22/06/23
LadRx Announces Reverse Stock Split Effective as of May 17, 2023	18/05/23
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
LadRx Announces Reverse Stock Split	10/05/23
LadRx Corporation has filed an IPO in the amount of $24 million.	14/04/23
LadRx Highlights Patent Issued for Its LADR Technology	27/03/23
LadRx Highlights Patent Issued for Its LADR Technology	27/03/23
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	20/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CytRx Corporation Nasdaq

Actions

US2328283013

Autres langues

Filtres